Medy-Tox Inc.
KOE: 086900.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hyun-Ho Jung
- Employees
- 721
- Headquarters
- Cheongju, South Korea
- IPO year
- 2009
- Market cap
- ₩680.9B
- Website
- https://www.medy-tox.co.kr
Loading 086900…
Loading profile data…Frequently asked questions about 086900
What does Medy-Tox Inc. (086900.KQ) do?
Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily...
Where does 086900.KQ trade?
Medy-Tox Inc. (086900.KQ) trades on the KOSDAQ.
What sector is 086900.KQ in?
Medy-Tox Inc. (086900.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Medy-Tox Inc.?
Hyun-Ho Jung is the chief executive officer of Medy-Tox Inc. (086900.KQ).
Where is Medy-Tox Inc. headquartered?
Medy-Tox Inc. is headquartered in South Korea.
Does 086900.KQ pay a dividend?
Yes — Medy-Tox Inc. (086900.KQ) paid a trailing twelve-month dividend of KRW 1200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 086900.KQ go public?
Medy-Tox Inc. (086900.KQ) completed its initial public offering in 2009.